ARTICLE | Clinical News
Beteflam Patch regulatory update
March 16, 2015 7:00 AM UTC
Health Canada accepted for review an NDS for Beteflam Patch from Cipher Pharmaceuticals Inc. (TSX:CPH; NASDAQ:CPHR, Mississauga, Ontario) to treat inflammatory skin conditions, including chronic plaq...